WinwinGPT 即將上線,加入 Waitlist 上線搶先用!

Laboratory corporation of america holdings

美股醫療保健

LH 投資分析

看多重點:

  • 價值≥4
  • 股利≥2

分析結論

價值面評分較低,若以價值投資為目標,已經有長期投資部位可能需陸續減碼

LH 近期報酬表現

1.43%

Laboratory corporation of america holdings

2.86%

同產業平均

0.86%

S&P500

與 LH 同產業的標的表現

  • DGX Quest diagnostics incorporated
    價值 1 分趨勢 3 分波段 5 分籌碼 2 分股利 5 分
    查看更多

LH 公司資訊

Laboratory Corporation of America Holdings provides comprehensive laboratory services that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. By leveraging its unparalleled diagnostics and drug development capabilities, the Company provides insights and accelerates innovations to improve health and improve lives. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company serves clients in more than 100 countries.

LH 股價